Commonwealth Equity Cuts GE HealthCare Stake by 34.4%, Wedge Capital Opens $26.86M Position
Commonwealth Equity Services LLC reduced its GE HealthCare stake by 34.4% in Q3, selling 91,088 shares to retain 173,486 shares valued at $13.03M. Wedge Capital Management opened a new GE HealthCare position worth $26.86M during the quarter.
1. Institutional Stake Reduction by Commonwealth Equity Services LLC
Commonwealth Equity Services LLC reduced its position in GE HealthCare Technologies Inc. by 34.4% during the third quarter, selling 91,088 shares and ending the period with 173,486 shares. According to its latest 13F filing, the remaining stake was valued at approximately $13.03 million. This divestment marks one of the largest single-quarter reductions in the company’s institutional holdings and reflects a reevaluation of portfolio allocations among major fund managers.
2. Mixed Movements Among Major Investors
Several other prominent institutional investors adjusted their stakes in GE HealthCare Technologies during the same period. Mirae Asset Global Investments Co. Ltd. increased its holding by 4.2% to 159,882 shares, valued at around $11.84 million. Wedge Capital Management initiated a new position worth about $26.86 million, while Lineweaver Wealth Advisors added a smaller stake valued at $592,000. Valicenti Advisory Services grew its position by 22.6% to 68,107 shares (approximately $5.12 million), and National Bank of Canada FI more than doubled its holding—up 133.3%—to 899,693 shares, representing about $66.64 million. Institutional investors collectively own over 82% of the company’s outstanding shares.
3. Recent Financial Performance and 2025 Guidance
In its latest quarterly report, GE HealthCare Technologies delivered adjusted earnings per share of $1.07, surpassing analysts’ consensus by $0.02, on revenues of $5.14 billion, ahead of the projected $5.07 billion and reflecting year-over-year revenue growth of 5.8%. The company reported a return on equity of 22.52% and a net margin of 10.94%. For fiscal year 2025, management set earnings guidance in a range of $4.510 to $4.630 per share, aligning closely with analysts’ average estimate of $4.68.
4. Dividend Policy and Analyst Consensus
GE HealthCare Technologies announced a quarterly dividend of $0.035 per share, payable February 13 to shareholders of record on January 9, implying an annualized payout of $0.14 and a dividend yield near 0.2%. The current payout ratio stands at 2.89%. On the research side, the company maintains a consensus rating of Moderate Buy, with seven analysts recommending a buy and seven advising a hold. The average price target among covering analysts is $89.50, suggesting modest upside potential from current levels.